|
1
|
Westphal M and Lamszus K: The neurobiology
of gliomas: From cell biology to the development of therapeutic
approaches. Nat Rev Neurosci. 12:495–508. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Furnari FB, Fenton T, Bachoo RM, Mukasa A,
Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al:
Malignant astrocytic glioma: Genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pollack IF: Neuro-oncology: Therapeutic
benefits of reirradiation for recurrent brain tumors. Nat Rev
Neurol. 6:533–535. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Khasraw M and Lassman AB: Neuro-oncology:
Late neurocognitive decline after radiotherapy for low-grade
glioma. Nat Rev Neurol. 5:646–647. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pang JC, Kwok WK, Chen Z and Ng HK:
Oncogenic role of microRNAs in brain tumors. Acta Neuropathol.
117:599–611. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Silber J, James CD and Hodgson JG:
microRNAs in gliomas: Small regulators of a big problem.
Neuromolecular Med. 11:208–222. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Manikandan J, Aarthi JJ, Kumar SD and
Pushparaj PN: Oncomirs: The potential role of non-coding microRNAs
in understanding cancer. Bioinformation. 2:330–334. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Dutta A and Abounader R: The role
of microRNAs in glioma initiation and progression. Front Biosci
(Landmark Ed). 17:700–712. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Besse A, Sana J, Fadrus P and Slaby O:
MicroRNAs involved in chemo- and radioresistance of high-grade
gliomas. Tumour Biol. 34:1969–1978. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao L, Bombard J, Cintron K, Sheedy J,
Weetall ML and Davis TW: BMI1 as a novel target for drug discovery
in cancer. J Cell Biochem. 112:2729–2741. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guney I, Wu S and Sedivy JM: Reduced c-Myc
signaling triggers telomere-independent senescence by regulating
Bmi-1 and p16INK4a. Proc Natl Acad Sci USA. 103:3645–3650. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Silva J, García JM, Peña C, García V,
Domínguez G, Suárez D, Camacho FI, Espinosa R, Provencio M, España
P, et al: Implication of polycomb members Bmi-1, Mel-18, and Hpc-2
in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression
in primary breast carcinomas. Clin Cancer Res. 12:6929–6936. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu J, Hu D, Yang G, Zhou J, Yang C, Gao Y
and Zhu Z: Down-regulation of BMI-1 cooperates with artemisinin on
growth inhibition of nasopharyngeal carcinoma cells. J Cell
Biochem. 112:1938–1948. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu Z, Min L, Chen D, Hao D, Duan Y, Qiu G
and Wang Y: Overexpression of BMI-1 promotes cell growth and
resistance to cisplatin treatment in osteosarcoma. PLoS One.
6:e146482011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jacobs JJ, Scheijen B, Voncken JW, Kieboom
K, Berns A and van Lohuizen M: Bmi-1 collaborates with c-Myc in
tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF.
Genes Dev. 13:2678–2690. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang L, Li J and Song L: Bmi-1, stem
cells and cancer. Acta Biochim Biophys Sin (Shanghai). 41:527–534.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Itahana K, Zou Y, Itahana Y, Martinez JL,
Beausejour C, Jacobs JJ, Van Lohuizen M, Band V, Campisi J and
Dimri GP: Control of the replicative life span of human fibroblasts
by p16 and the polycomb protein Bmi-1. Mol Cell Biol. 23:389–401.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qiu M, Liang Z, Chen L, Tan G, Wang K, Liu
L, Liu J and Chen H: MicroRNA-429 suppresses cell proliferation,
epithelial-mesenchymal transition, and metastasis by direct
targeting of BMI1 and E2F3 in renal cell carcinoma. Urol Oncol.
33:332.e9–18. 2015. View Article : Google Scholar
|
|
23
|
Wei XL, Dou XW, Bai JW, Luo XR, Qiu SQ, Xi
DD, Huang WH, Du CW, Man K and Zhang GJ: ERα inhibits
epithelial-mesenchymal transition by suppressing Bmi1 in breast
cancer. Oncotarget. 6:21704–21717. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Paranjape AN, Balaji SA, Mandal T, Krushik
EV, Nagaraj P, Mukherjee G and Rangarajan A: Bmi1 regulates
self-renewal and epithelial to mesenchymal transition in breast
cancer cells through Nanog. BMC Cancer. 14:7852014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liang J, Wang P, Xie S, Wang W, Zhou X, Hu
J, Shi Q, Zhang X and Yu R: Bmi-1 regulates the migration and
invasion of glioma cells through p16. Cell Biol Int. 39:283–290.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tu Y, Gao X, Li G, Fu H, Cui D, Liu H, Jin
W and Zhang Y: MicroRNA-218 inhibits glioma invasion, migration,
proliferation, and cancer stem-like cell self-renewal by targeting
the polycomb group gene Bmi1. Cancer Res. 73:6046–6055. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiang L, Song L, Wu J, Yang Y, Zhu X, Hu
B, Cheng SY and Li M: Bmi-1 promotes glioma angiogenesis by
activating NF-κB signaling. PLoS One. 8:e555272013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang L, Wu J, Yang Y, Liu L, Song L, Li J
and Li M: Bmi-1 promotes the aggressiveness of glioma via
activating the NF-kappaB/MMP-9 signaling pathway. BMC Cancer.
12:4062012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou L, Di Q, Sun B, Wang X, Li M and Shi
J: MicroRNA-194 restrains the cell progression of non-small cell
lung cancer by targeting human nuclear distribution protein C.
Oncol Rep. 35:3435–3444. 2016.PubMed/NCBI
|
|
30
|
Zhao Y, Li F, Zhang X, Liu A, Qi J, Cui H
and Zhao P: MicroRNA-194 acts as a prognostic marker and inhibits
proliferation in hepatocellular carcinoma by targeting MAP4K4. Int
J Clin Exp Pathol. 8:12446–12454. 2015.PubMed/NCBI
|
|
31
|
Zhao HJ, Ren LL, Wang ZH, Sun TT, Yu YN,
Wang YC, Yan TT, Zou W, He J, Zhang Y, et al: MiR-194 deregulation
contributes to colorectal carcinogenesis via targeting AKT2
pathway. Theranostics. 4:1193–1208. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kwak PB, Iwasaki S and Tomari Y: The
microRNA pathway and cancer. Cancer Sci. 101:2309–2315. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Karsy M, Arslan E and Moy F: Current
progress on understanding MicroRNAs in glioblastoma multiforme.
Genes Cancer. 3:3–15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tivnan A and McDonald KL: Current progress
for the use of miRNAs in glioblastoma treatment. Mol Neurobiol.
48:757–768. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chiang Y, Song Y, Wang Z, Liu Z, Gao P,
Liang J, Zhu J, Xing C and Xu H: microRNA-192, −194 and −215 are
frequently downregulated in colorectal cancer. Exp Ther Med.
3:560–566. 2012.PubMed/NCBI
|
|
36
|
Basati G, Razavi AE, Pakzad I and Malayeri
FA: Circulating levels of the miRNAs, miR-194, and miR-29b, as
clinically useful biomarkers for colorectal cancer. Tumour Biol.
37:1781–1788. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang B, Shen ZL, Gao ZD, Zhao G, Wang CY,
Yang Y, Zhang JZ, Yan YC, Shen C, Jiang KW, et al: MiR-194,
commonly repressed in colorectal cancer, suppresses tumor growth by
regulating the MAP4K4/c-Jun/MDM2 signaling pathway. Cell Cycle.
14:1046–1058. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu X, Liu T, Fang O, Leach LJ, Hu X and
Luo Z: miR-194 suppresses metastasis of non-small cell lung cancer
through regulating expression of BMP1 and p27kip1. Oncogene.
33:1506–1514. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhu X, Li D, Yu F, Jia C, Xie J, Ma Y, Fan
S, Cai H, Luo Q, Lv Z, et al: miR-194 inhibits the proliferation,
invasion, migration, and enhances the chemosensitivity of non-small
cell lung cancer cells by targeting forkhead box A1 protein.
Oncotarget. 7:13139–13152. 2016.PubMed/NCBI
|
|
40
|
Chen X, Wang Y, Zang W, Du Y, Li M and
Zhao G: miR-194 targets RBX1 gene to modulate proliferation and
migration of gastric cancer cells. Tumour Biol. 36:2393–2401. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li Z, Ying X, Chen H, Ye P, Shen Y, Pan W
and Zhang L: MicroRNA-194 inhibits the epithelial-mesenchymal
transition in gastric cancer cells by targeting FoxM1. Dig Dis Sci.
59:2145–2152. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chi H: miR-194 regulated AGK and inhibited
cell proliferation of oral squamous cell carcinoma by reducing
PI3K-Akt-FoxO3a signaling. Biomed Pharmacother. 71:53–57. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang M, Zhuang Q and Cui L: MiR-194
inhibits cell proliferation and invasion via repression of RAP2B in
bladder cancer. Biomed Pharmacother. 80:268–275. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nofech-Mozes R, Khella HW, Scorilas A,
Youssef L, Krylov SN, Lianidou E, Sidiropoulos KG, Gabril M, Evans
A and Yousef GM: MicroRNA-194 is a marker for good prognosis in
clear cell renal cell carcinoma. Cancer Med. 5:656–664. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang J, Zhao CY, Zhang SH, Yu DH, Chen Y,
Liu QH, Shi M, Ni CR and Zhu MH: Upregulation of miR-194
contributes to tumor growth and progression in pancreatic ductal
adenocarcinoma. Oncol Rep. 31:1157–1164. 2014.PubMed/NCBI
|
|
46
|
Kamijo T: Role of stemness-related
molecules in neuroblastoma. Pediatr Res. 71:511–515. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ren H, Du P, Ge Z, Jin Y, Ding D, Liu X
and Zou Q: TWIST1 and BMI1 in cancer metastasis and
chemoresistance. J Cancer. 7:1074–1080. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yuan W, Yuan Y, Zhang T and Wu S: Role of
Bmi-1 in regulation of ionizing irradiation-induced
epithelial-mesenchymal transition and migration of breast cancer
cells. PLoS One. 10:e01187992015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY,
Yang WH, Huang CH, Kao SY, Tzeng CH, Tai SK, et al: Bmi1 is
essential in Twist1-induced epithelial-mesenchymal transition. Nat
Cell Biol. 12:982–992. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Leung C, Lingbeek M, Shakhova O, Liu J,
Tanger E, Saremaslani P, Van Lohuizen M and Marino S: Bmi1 is
essential for cerebellar development and is overexpressed in human
medulloblastomas. Nature. 428:337–341. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Molofsky AV, Pardal R, Iwashita T, Park
IK, Clarke MF and Morrison SJ: Bmi-1 dependence distinguishes
neural stem cell self-renewal from progenitor proliferation.
Nature. 425:962–967. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wu Z, Wang Q, Wang L, Li G, Liu H, Fan F,
Li Z, Li Y and Tu Y: Combined aberrant expression of Bmi1 and EZH2
is predictive of poor prognosis in glioma patients. J Neurol Sci.
335:191–196. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Sun P, Mu Y and Zhang S: A novel
NF-κB/MMP-3 signal pathway involves in the aggressivity of glioma
promoted by Bmi-1. Tumour Biol. 35:12721–12727. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Dong P, Kaneuchi M, Watari H, Hamada J,
Sudo S, Ju J and Sakuragi N: MicroRNA-194 inhibits epithelial to
mesenchymal transition of endometrial cancer cells by targeting
oncogene BMI-1. Mol Cancer. 10:992011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Deng Y, Xiong Y and Liu Y: miR-376c
inhibits cervical cancer cell proliferation and invasion by
targeting BMI1. Int J Exp Pathol. 97:257–265. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Weng JH, Yu CC, Lee YC, Lin CW, Chang WW
and Kuo YL: miR-494-3p induces cellular senescence and enhances
radiosensitivity in human oral squamous carcinoma cells. Int J Mol
Sci. 17:172016. View Article : Google Scholar
|
|
57
|
He Z, Xia Y, Pan C, Ma T, Liu B, Wang J,
Chen L and Chen Y: Up-regulation of miR-452 inhibits metastasis of
non-small cell lung cancer by regulating BMI1. Cell Physiol
Biochem. 37:387–398. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Chen T, Xu C, Chen J, Ding C, Xu Z, Li C
and Zhao J: MicroRNA-203 inhibits cellular proliferation and
invasion by targeting Bmi1 in non-small cell lung cancer. Oncol
Lett. 9:2639–2646. 2015.PubMed/NCBI
|
|
59
|
Cheng Y, Yang X, Deng X, Zhang X, Li P,
Tao J and Lu Q: MicroRNA-218 inhibits bladder cancer cell
proliferation, migration, and invasion by targeting BMI-1. Tumour
Biol. 36:8015–8023. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang T, Chen T, Niu H, Li C, Xu C, Li Y,
Huang R, Zhao J and Wu S: MicroRNA-218 inhibits the proliferation
and metastasis of esophageal squamous cell carcinoma cells by
targeting BMI1. Int J Mol Med. 36:93–102. 2015.PubMed/NCBI
|
|
61
|
Xuan H, Xue W, Pan J, Sha J, Dong B and
Huang Y: Downregulation of miR-221, −30d, and −15a contributes to
pathogenesis of prostate cancer by targeting Bmi-1. Biochemistry
(Mosc). 80:276–283. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Liu L, Qiu M, Tan G, Liang Z, Qin Y, Chen
L, Chen H and Liu J: miR-200c inhibits invasion, migration and
proliferation of bladder cancer cells through down-regulation of
BMI-1 and E2F3. J Transl Med. 12:3052014. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Qi X, Li J, Zhou C, Lv C and Tian M:
MicroRNA-320a inhibits cell proliferation, migration and invasion
by targeting BMI-1 in nasopharyngeal carcinoma. FEBS Lett.
588:3732–3738. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Kahlert UD, Nikkhah G and Maciaczyk J:
Epithelial-to-mesenchymal(−like) transition as a relevant molecular
event in malignant gliomas. Cancer Lett. 331:131–138. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Elias MC, Tozer KR, Silber JR, Mikheeva S,
Deng M, Morrison RS, Manning TC, Silbergeld DL, Glackin CA, Reh TA,
et al: TWIST is expressed in human gliomas and promotes invasion.
Neoplasia. 7:824–837. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Han SP, Kim JH, Han ME, Sim HE, Kim KS,
Yoon S, Baek SY, Kim BS and Oh SO: SNAI1 is involved in the
proliferation and migration of glioblastoma cells. Cell Mol
Neurobiol. 31:489–496. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Mikheeva SA, Mikheev AM, Petit A, Beyer R,
Oxford RG, Khorasani L, Maxwell JP, Glackin CA, Wakimoto H,
González-Herrero I, et al: TWIST1 promotes invasion through
mesenchymal change in human glioblastoma. Mol Cancer. 9:1942010.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Pang H, Zheng Y, Zhao Y, Xiu X and Wang J:
miR-590-3p suppresses cancer cell migration, invasion and
epithelial-mesenchymal transition in glioblastoma multiforme by
targeting ZEB1 and ZEB2. Biochem Biophys Res Commun. 468:739–745.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Li J, Yuan J, Yuan X, Zhao J, Zhang Z,
Weng L and Liu J: MicroRNA-200b inhibits the growth and metastasis
of glioma cells via targeting ZEB2. Int J Oncol. 48:541–550.
2016.PubMed/NCBI
|
|
70
|
He X, Liu Z, Peng Y and Yu C:
MicroRNA-181c inhibits glioblastoma cell invasion, migration and
mesenchymal transition by targeting TGF-β pathway. Biochem Biophys
Res Commun. 469:1041–1048. 2016. View Article : Google Scholar : PubMed/NCBI
|
